Exploring, Predicting, and Intervening on Long-term Viral Suppression Electronically

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Despite the widespread availability of effective antiretroviral therapy (ART) in the United States, there remains significant numbers of people living with HIV (PLWH) who fail to achieve and or maintain viral suppression (VS). Disparities persist with the lowest levels of VS among Black individuals, people who use drugs, youth ages 18-24 and people residing in rural areas. Investigators will examine the syndemics underlying these outcomes including substance use, mental health, and barriers to HIV care including racial discrimination, stigma and rural isolation.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

• Have access to a personal smartphone device;

• Over 18 years of age;

• Speak English or Spanish;

• Living with HIV

• Are either 1) not currently virally suppressed, 2) not currently engaged in care, or 3) have one or more factors associated with viral non suppression including a history of missed appointments or viral non suppression;

• Active substance use or mental health disorder;

• Willing and able to provide written informed consent to take part in the study.

Locations
United States
California
University of California, Los Angeles
RECRUITING
Los Angeles
Contact Information
Primary
Pamina Gorbach, DrPh
RemainApp@ph.ucla.edu
(628) 226-1863
Backup
Valerie El-Alfi, MA
RemainApp@ph.ucla.edu
Time Frame
Start Date: 2024-02-09
Estimated Completion Date: 2028-04-30
Participants
Target number of participants: 1000
Treatments
Other: Download the REMAIN App
All participants download the app
Related Therapeutic Areas
Sponsors
Collaborators: National Institute of Allergy and Infectious Diseases (NIAID), Florida State University, University of California, Irvine, AIDS Healthcare Foundation, University of North Carolina, Chapel Hill
Leads: University of California, Los Angeles

This content was sourced from clinicaltrials.gov